Stock Information
Prelude Therapeutics Inc (PRLD)
Ticker Symbol: PRLD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $434.86 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.73
Revenue (TTM): $0.23 M
Dividend Yield: N/A
ROE: -75.35%
Latest News
-
Prelude Therapeutics to Participate in the Chardan Healthcare Conference
Fri, Oct 16, 2026 8:01 PM
-
Down 27.4% in 4 Weeks, Here's Why Prelude Therapeutics (PRLD) Looks Ripe for a Turnaround
Fri, Oct 16, 2026 12:35 PM
-
Eli Lilly (LLY) Reported One Year Steroid Free Control In Difficult IBD
Thu, Oct 15, 2026 6:13 PM
Key Financials
Financial data not available
